Prostaglandin E2 receptor subtypes in human blood and vascular cells

被引:23
作者
Foudi, Nabil [1 ]
Gomez, Ingrid [2 ,3 ]
Benyahia, Chabha [2 ,3 ]
Longrois, Dan [2 ,4 ]
Norel, Xavier [2 ,3 ]
机构
[1] Ferhat Abbas Univ, Fac Med, Dept Pharm, Setif 19000, Algeria
[2] CHU Xavier Bichat, INSERM U698, F-75018 Paris, France
[3] Univ Paris 13, UMR S698, F-75018 Paris, France
[4] Univ Paris Diderot, Sorbonne Paris Cite,Dept Anesthesia & Intens Care, CHU X Bichat, UMR S698, F-75018 Paris, France
关键词
Prostaglandin; Blood cell; Endothelium; Smooth muscle cell; Atherosclerosis; Vascular tone; INHIBITS PLATELET-AGGREGATION; ENDOTHELIAL GROWTH-FACTOR; EP4; RECEPTOR; PROSTANOID RECEPTORS; HUMAN MONOCYTES; CYCLIC-AMP; MAST-CELLS; ATHEROSCLEROTIC PLAQUES; CEREBRAL ANEURYSM; INDUCED APOPTOSIS;
D O I
10.1016/j.ejphar.2012.08.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prostaglandin E-2 is produced in inflammatory responses via the cyclooxygenase pathway and regulates a variety of physiological and pathological reactions through four different receptor subtypes; EP1, EP2, EP3 and EP4. The role of the classical prostanoid receptors stimulated by prostaglandin I-2 and thromboxane A(2) in the blood circulation has been largely studied, whereas the other receptors such as EP activated by prostaglandin E-2, have been recently shown to be also implicated. There is now increasing evidence suggesting an important role of EP3 and EP4 receptor subtypes in the control of the human vascular tone and remodeling of the vascular wall as well in platelet aggregation and thrombosis. These receptors are implicated in vascular homeostasis and in the development of some pathological situations, such as atherosclerosis, aneurysms and hypertension. The use of specific EP agonists/antagonists would provide a novel cardiovascular therapeutic approach. In this review, we discuss the role of prostaglandin E-2 receptors in the control of human blood and vascular cells. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 88 条
[81]   CHARACTERIZATION OF THE INHIBITORY PROSTANOID RECEPTORS ON HUMAN NEUTROPHILS [J].
WHEELDON, A ;
VARDEY, CJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (04) :1051-1054
[82]   International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress [J].
Woodward, D. F. ;
Jones, R. L. ;
Narumiya, S. .
PHARMACOLOGICAL REVIEWS, 2011, 63 (03) :471-538
[83]   The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway [J].
Yang, Li-xia ;
Ye, Jin-shan ;
Guo, Rui-wei ;
Liu, Hong ;
Wang, Xian-mei ;
Qi, Feng ;
Guo, Chuanming .
INFLAMMATION RESEARCH, 2010, 59 (12) :1033-1040
[84]   The Role of PGE2 Receptor EP4 in Pathologic Ocular Angiogenesis [J].
Yanni, Susan E. ;
Barnett, Joshua M. ;
Clark, Monika L. ;
Penn, John S. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (11) :5479-5486
[85]  
Zeng L, 1998, J PHARMACOL EXP THER, V286, P1420
[86]   Selective regulation of RNK-16 cell matrix metalloproteinases by the EP(4) subtype of prostaglandin E(2) receptor [J].
Zeng, L ;
An, SZ ;
Goetzl, EJ .
BIOCHEMISTRY, 1996, 35 (22) :7159-7164
[87]  
Zeng L, 1995, IMMUNOLOGY, V86, P620
[88]   PGE2 promotes angiogenesis through EP4 and PKACγ pathway [J].
Zhang, Yushan ;
Daaka, Yehia .
BLOOD, 2011, 118 (19) :5355-5364